Effect of Sacubitril/Valsartan on Reducing the Risk of Arrhythmia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Effect of Sacubitril/Valsartan on Reducing the Risk of Arrhythmia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background and ObjectiveRelevant data of PARADIGM-HF reveals sacubitril/valsartan (SV) therapy led to a greater reduction in the risks of arrhythmia, and sudden cardiac death than angiotensin converting enzyme inhibitor (ACEI)/angiotensin receptor inhibitor (ARB) therapy in HFrEF, however, inconsist...

Full description

Bibliographic Details
Main Authors: Ruxin Wang, Haowen Ye, Li Ma, Jinjing Wei, Ying Wang, Xiaofang Zhang, Lihong Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
sacubitril/valsartan
arrhythmia
atrial arrhythmia
ventricular arrhythmia
cardiac arrest
ACEI
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.890481/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.890481/full

Similar Items